$QURE
uniQure N.V.

2020 Q1 Form 10-K Financial Statement

#000155837020001883 Filed on March 02, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2018 Q4 2017 Q4
Revenue $104.0K $1.610M $2.580M
YoY Change -90.85% -37.6% -71.74%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.072M $7.210M $7.280M
YoY Change 12.46% -0.96% 26.61%
% of Gross Profit
Research & Development $26.01M $18.42M $18.21M
YoY Change 26.66% 1.15% -9.31%
% of Gross Profit
Depreciation & Amortization $1.730M $1.970M $1.500M
YoY Change 10.19% 31.33% -3.23%
% of Gross Profit
Operating Expenses $35.09M $25.81M $25.23M
YoY Change 22.66% 2.3% -1.14%
Operating Profit -$34.46M
YoY Change 25.3%
Interest Expense $975.0K $1.770M -$2.290M
YoY Change 1.88% -177.29% -198.28%
% of Operating Profit
Other Income/Expense, Net $339.0K $540.0K -$2.460M
YoY Change -2.87% -121.95% -3175.0%
Pretax Income -$28.00M -$21.89M -$27.40M
YoY Change 0.82% -20.11% 95.99%
Income Tax -$10.00K $1.780M
% Of Pretax Income
Net Earnings -$28.00M -$21.89M -$27.47M
YoY Change 0.82% -20.31% 86.62%
Net Earnings / Revenue -26922.12% -1359.63% -1064.73%
Basic Earnings Per Share
Diluted Earnings Per Share -$632.3K -$586.2K -$877.6K
COMMON SHARES
Basic Shares Outstanding 44.25M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2018 Q4 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $342.0M $234.9M $159.4M
YoY Change 63.79% 47.37% 20.3%
Cash & Equivalents $342.0M $234.9M $159.4M
Short-Term Investments
Other Short-Term Assets $1.576M $329.0K $1.800M
YoY Change -60.6% -81.72% -21.74%
Inventory
Prepaid Expenses $5.738M $1.116M
Receivables $300.0K $200.0K $1.600M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $349.6M $236.6M $162.8M
YoY Change 63.98% 45.32% 13.13%
LONG-TERM ASSETS
Property, Plant & Equipment $27.74M $29.18M $34.30M
YoY Change -40.35% -14.93% -3.92%
Goodwill $486.0K $506.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.900M $2.400M $2.500M
YoY Change 0.0% -4.0% 38.89%
Total Long-Term Assets $64.64M $37.33M $46.80M
YoY Change 15.85% -20.24% 0.86%
TOTAL ASSETS
Total Short-Term Assets $349.6M $236.6M $162.8M
Total Long-Term Assets $64.64M $37.33M $46.80M
Total Assets $414.2M $273.9M $209.6M
YoY Change 53.99% 30.68% 10.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.989M $3.792M $2.900M
YoY Change 42.54% 30.76% -47.27%
Accrued Expenses $9.507M $8.232M $8.000M
YoY Change -14.35% 2.9% -18.37%
Deferred Revenue $6.732M $7.634M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $1.100M
YoY Change -100.0% 83.33%
Total Short-Term Liabilities $27.13M $19.97M $19.20M
YoY Change 21.11% 4.01% -15.42%
LONG-TERM LIABILITIES
Long-Term Debt $36.21M $35.47M $19.70M
YoY Change 1.71% 80.06% 0.51%
Other Long-Term Liabilities $524.0K $435.0K $81.30M
YoY Change -99.03% -99.46% -3.56%
Total Long-Term Liabilities $91.97M $74.33M $101.0M
YoY Change 2.87% -26.4% -2.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.13M $19.97M $19.20M
Total Long-Term Liabilities $91.97M $74.33M $101.0M
Total Liabilities $119.1M $94.30M $120.3M
YoY Change 6.43% -21.61% -4.98%
SHAREHOLDERS EQUITY
Retained Earnings -$687.7M -$535.5M
YoY Change
Common Stock $2.683M $2.299M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $295.1M $179.6M $89.36M
YoY Change
Total Liabilities & Shareholders Equity $414.2M $273.9M $209.6M
YoY Change 53.99% 30.68% 10.14%

Cashflow Statement

Concept 2020 Q1 2018 Q4 2017 Q4
OPERATING ACTIVITIES
Net Income -$28.00M -$21.89M -$27.47M
YoY Change 0.82% -20.31% 86.62%
Depreciation, Depletion And Amortization $1.730M $1.970M $1.500M
YoY Change 10.19% 31.33% -3.23%
Cash From Operating Activities -$32.95M -$18.01M -$18.05M
YoY Change 24.64% -0.22% 15.19%
INVESTING ACTIVITIES
Capital Expenditures $677.0K -$750.0K -$1.210M
YoY Change 189.32% -38.02% -71.46%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.890M -$750.0K -$640.0K
YoY Change 134.96% 17.19% -82.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.010M
YoY Change -53.63%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.010M 14.84M 89.03M
YoY Change -62.29% -83.33% 23328.95%
NET CHANGE
Cash From Operating Activities -32.95M -18.01M -18.05M
Cash From Investing Activities -2.890M -750.0K -640.0K
Cash From Financing Activities 1.010M 14.84M 89.03M
Net Change In Cash -35.78M -3.920M 70.34M
YoY Change 39.61% -105.57% -471.97%
FREE CASH FLOW
Cash From Operating Activities -$32.95M -$18.01M -$18.05M
Capital Expenditures $677.0K -$750.0K -$1.210M
Free Cash Flow -$33.63M -$17.26M -$16.84M
YoY Change 26.09% 2.49% 47.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
761000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43711954
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37351653
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001590560
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Entity File Number
EntityFileNumber
001-36294
CY2019 dei Entity Registrant Name
EntityRegistrantName
uniQure N.V.
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
P7
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
Paasheuvelweg 25a
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
1105 BP Amsterdam
CY2019 dei Entity Address Country
EntityAddressCountry
NL
CY2019 dei City Area Code
CityAreaCode
31
CY2019 dei Local Phone Number
LocalPhoneNumber
20-240-6000
CY2019 dei Security12b Title
Security12bTitle
Ordinary shares, par value €0.05 per share
CY2019 dei Trading Symbol
TradingSymbol
QURE   
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Small Business
EntitySmallBusiness
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019Q2 dei Entity Public Float
EntityPublicFloat
2957200000
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44254903
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
377793000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
234898000
CY2019Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
947000
CY2018Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
233000
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4718000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1116000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
748000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
329000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
384206000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
236576000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28771000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29179000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26797000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5427000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5201000
CY2019Q4 us-gaap Goodwill
Goodwill
496000
CY2018Q4 us-gaap Goodwill
Goodwill
506000
CY2019 us-gaap Other Income
OtherIncome
1888000
CY2018 us-gaap Other Income
OtherIncome
2146000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
2933000
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
2444000
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
64424000
CY2018Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
37330000
CY2019Q4 us-gaap Assets
Assets
448630000
CY2018Q4 us-gaap Assets
Assets
273906000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5681000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3792000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12457000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8232000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5865000
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
311000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7627000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7634000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
31630000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19969000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
36062000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
35471000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31133000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
8761000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
23138000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
28861000
CY2019Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3075000
CY2018Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
803000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
534000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
435000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
93942000
CY2018Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
74331000
CY2019Q4 us-gaap Liabilities
Liabilities
125572000
CY2018Q4 us-gaap Liabilities
Liabilities
94300000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43711954
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37351653
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
2651000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
2299000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
986803000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
720072000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6689000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7259000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-659707000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-535506000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
323058000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
179606000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
448630000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
273906000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7281000
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11284000
CY2017 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13107000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
94737000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
74809000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
72172000
CY2017 us-gaap Other Income
OtherIncome
15430000
CY2019 us-gaap Other Expenses
OtherExpenses
2028000
CY2018 us-gaap Other Expenses
OtherExpenses
1548000
CY2017 us-gaap Other Expenses
OtherExpenses
3073000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
33544000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25305000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24635000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
128281000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
100114000
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
96807000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-83304000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5261000
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
138361000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4760000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10708000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-121140000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-88232000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-71343000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
3547000
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
2729000
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
117000
CY2019 us-gaap Interest Expense
InterestExpense
3810000
CY2018 us-gaap Interest Expense
InterestExpense
2160000
CY2017 us-gaap Interest Expense
InterestExpense
2232000
CY2019 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-268000
CY2018 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4382000
CY2017 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3566000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2530000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
208000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2435000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-124201000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-83073000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-79459000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
231000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-199000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-124201000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-83304000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-79260000
CY2019 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0
CY2018 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
-200000
CY2017 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
200000
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
570000
CY2018 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-5261000
CY2017 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2757000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-123631000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-88565000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-76503000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3110
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2340
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2940
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39999450
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35639745
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26984183
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
63631000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-79260000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2757000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
85290000
CY2017 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
588000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4120000
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
1953000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10280000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
89359000
CY2018 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
24918000
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
65000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
179606000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-124201000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
570000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
242674000
CY2019 qure Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1273000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5235000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17533000
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
368000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
323058000
CY2019 us-gaap Profit Loss
ProfitLoss
-124201000
CY2018 us-gaap Profit Loss
ProfitLoss
-83304000
CY2017 us-gaap Profit Loss
ProfitLoss
-79260000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6669000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12415000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7543000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
17533000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
10708000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
10280000
CY2019 qure Change In Fair Value Of Derivative Financial Instruments And Contingent Consideration
ChangeInFairValueOfDerivativeFinancialInstrumentsAndContingentConsideration
2530000
CY2018 qure Change In Fair Value Of Derivative Financial Instruments And Contingent Consideration
ChangeInFairValueOfDerivativeFinancialInstrumentsAndContingentConsideration
-4054000
CY2017 qure Change In Fair Value Of Derivative Financial Instruments And Contingent Consideration
ChangeInFairValueOfDerivativeFinancialInstrumentsAndContingentConsideration
5194000
CY2019 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-891000
CY2018 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
5502000
CY2017 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-4222000
CY2018 qure Change In Deferred Tax Expense
ChangeInDeferredTaxExpense
231000
CY2017 qure Change In Deferred Tax Expense
ChangeInDeferredTaxExpense
209000
CY2018 qure Change In Lease Incentive
ChangeInLeaseIncentive
-330000
CY2017 qure Change In Lease Incentive
ChangeInLeaseIncentive
2215000
CY2019 qure Increase Decrease In Accounts Receivable Prepaid Expense And Other Current Assets
IncreaseDecreaseInAccountsReceivablePrepaidExpenseAndOtherCurrentAssets
4769000
CY2018 qure Increase Decrease In Accounts Receivable Prepaid Expense And Other Current Assets
IncreaseDecreaseInAccountsReceivablePrepaidExpenseAndOtherCurrentAssets
-1578000
CY2017 qure Increase Decrease In Accounts Receivable Prepaid Expense And Other Current Assets
IncreaseDecreaseInAccountsReceivablePrepaidExpenseAndOtherCurrentAssets
-9715000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1652000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1065000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1670000
CY2019 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6010000
CY2018 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-382000
CY2017 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1640000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4999000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-8462000
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-21078000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-98684000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76037000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-64270000
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
996000
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1861000
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1122000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5651000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2384000
CY2017 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7306000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4461000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6647000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4245000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5583000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5603000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4825000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4044000
CY2017 qure Proceeds From Exercise Of Convertible Loan Warrants
ProceedsFromExerciseOfConvertibleLoanWarrants
1322000
CY2019 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
242718000
CY2018 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
138361000
CY2017 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
85290000
CY2018 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
14775000
CY2017 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
582000
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
500000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
143384000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
75491000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
27527000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
248821000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
157961000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
90074000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-106000
CY2018 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2187000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
161851000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
134324000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
380726000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
237342000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
161851000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
377793000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
234898000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
159371000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
2933000
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
2444000
CY2017Q4 us-gaap Restricted Cash
RestrictedCash
2480000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
237342000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
380726000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
237342000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
161851000
CY2019 qure Cash Paid Or Received Relating To Interest
CashPaidOrReceivedRelatingToInterest
-3117000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
2141000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
1624000
CY2019 qure Increase Decrease In Accounts Payable And Accrued Liabilities Related To Non Current Assets
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedToNonCurrentAssets
313000
CY2018 qure Increase Decrease In Accounts Payable And Accrued Liabilities Related To Non Current Assets
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedToNonCurrentAssets
-48000
CY2017 qure Increase Decrease In Accounts Payable And Accrued Liabilities Related To Non Current Assets
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedToNonCurrentAssets
-1557000
CY2019 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">1.</b></span><b style="font-weight:bold;">General business information</b></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">uniQure (the “Company”) was incorporated on January 9, 2012 as a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) under the laws of the Netherlands. The Company is a leader in the field of gene therapy and seeks to deliver to patients suffering from rare and other devastating diseases single treatments with potentially curative results. The Company’s business was founded in 1998 and was initially operated through its predecessor company, Amsterdam Molecular Therapeutics (AMT) Holding N.V (“AMT”). In 2012, AMT undertook a corporate reorganization, pursuant to which uniQure B.V. acquired the entire business and assets of AMT and completed a share-for-share exchange with the shareholders of AMT. Effective February 10, 2014, in connection with its initial public offering, the Company converted into a public company with limited liability (naamloze vennootschap) and changed its legal name from uniQure B.V. to uniQure N.V.</p><p style="font-family:'Times New Roman';font-size:11pt;text-align:justify;margin:0pt 1pt 0pt 1pt;"><span style="font-size:10pt;margin-left:0pt;margin-right:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The Company is registered in the trade register of the Dutch Chamber of Commerce (Kamer van Koophandel) under number 54385229. The Company’s headquarters are in Amsterdam, the Netherlands, and its registered office is located at Paasheuvelweg 25a, Amsterdam 1105 BP, the Netherlands and its telephone number is +31 20 240 6000. The Company’s website address is www.uniqure.com. </p><p style="font-family:'Times New Roman';font-size:11pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The Company’s ordinary shares are listed on the NASDAQ Global Select Market and trades under the symbol “QURE”.</p>
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-weight:bold;margin:0pt;">2.2<span style="font-weight:normal;">         </span>Use of estimates</p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The preparation of consolidated financial statements, in conformity with U.S. GAAP and SEC rules and regulations, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Estimates and assumptions are primarily made in relation to revenue recognition in the determination and measurement of performance obligations and assessment of the performance period over which license revenue is recognized, income taxes, including the realization of deferred tax assets, fair value of derivative financial instruments, share-based compensation, measurement of accrued expenses which have not yet been invoiced as of the balance sheet date and business combinations including contingent consideration payable. If actual results differ from the Company’s estimates, or to the extent these estimates are adjusted in future periods, the Company’s results of operations could either benefit from, or be adversely affected by, any such change in estimate.</p>
CY2019 qure Operating Cycle Period
OperatingCyclePeriod
P12M
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2018Q4 qure Deferred Rent Credit Current And Noncurrent
DeferredRentCreditCurrentAndNoncurrent
9100000
CY2019 qure Collaborative Arrangement Cost Sharing Percentage
CollaborativeArrangementCostSharingPercentage
0.50
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1900000
CY2017 qure Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Exercises Of Convertible Loan Warrants
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExercisesOfConvertibleLoanWarrants
-631000
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
5194000
CY2017 qure Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Of Contingent Consideration Paid
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisOfContingentConsiderationPaid
-1181000
CY2017 qure Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Currency Translation Effects
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslationEffects
-317000
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
5599000
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-4054000
CY2018 qure Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Currency Translation Effects
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslationEffects
-170000
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1375000
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
2530000
CY2019 qure Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Exercise Of Warrants
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationExerciseOfWarrants
770000
CY2019 qure Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Currency Translation Effects
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyTranslationEffects
-60000
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3075000
CY2019Q4 qure Number Of Warrant Types
NumberOfWarrantTypes
2
CY2017Q3 qure Percentage Of Future Milestones That Can Be Settled With Ordinary Shares Reduced Rate
PercentageOfFutureMilestonesThatCanBeSettledWithOrdinarySharesReducedRate
0.50
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
64648
CY2014 qure Percentage Of Future Milestones That Can Be Settled With Ordinary Shares
PercentageOfFutureMilestonesThatCanBeSettledWithOrdinaryShares
1
CY2017 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2300000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57396000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52073000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28625000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22894000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28771000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29179000
CY2019 us-gaap Depreciation
Depreciation
6000000.0
CY2018 us-gaap Depreciation
Depreciation
6500000
CY2017 us-gaap Depreciation
Depreciation
7000000.0
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28771000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29179000
CY2018Q4 us-gaap Area Of Land
AreaOfLand
30655
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
4474000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
507000
CY2019 us-gaap Sublease Income
SubleaseIncome
1053000
CY2019 us-gaap Lease Cost
LeaseCost
3928000
CY2017Q4 us-gaap Incentive To Lessee
IncentiveToLessee
12200000
CY2018Q4 us-gaap Incentive To Lessee
IncentiveToLessee
12200000
CY2018 us-gaap Operating Lease Expense
OperatingLeaseExpense
3250000
CY2017 us-gaap Operating Lease Expense
OperatingLeaseExpense
3606000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26797000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5865000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31133000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
36998000
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y3M18D
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1133
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
4717000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9002000
CY2019 qure Operating Leases Landlord Incentive Payments Received
OperatingLeasesLandlordIncentivePaymentsReceived
1500000
CY2019 qure Amount Capitalized Of Right Of Use Assets
AmountCapitalizedOfRightOfUseAssets
19000000.0
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5866000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5488000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5444000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5542000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
6038000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
33829000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
62207000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
25209000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
36998000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5865000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31133000
CY2019Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.12
CY2019 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P10Y8M12D
CY2019 qure Capitalized Expenditures Related To Milestone Payments
CapitalizedExpendituresRelatedToMilestonePayments
1000000.0
CY2018 qure Capitalized Expenditures Related To Milestone Payments
CapitalizedExpendituresRelatedToMilestonePayments
1900000
CY2019Q4 qure Accruals For Services Provided By Vendors Not Yet Billed Current
AccrualsForServicesProvidedByVendorsNotYetBilledCurrent
5425000
CY2018Q4 qure Accruals For Services Provided By Vendors Not Yet Billed Current
AccrualsForServicesProvidedByVendorsNotYetBilledCurrent
1999000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7032000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5688000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
545000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12457000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8232000
CY2019Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
50000000.0
CY2019 qure Long Term Debt Maturities Coupon Interest Payments And Financing Fees
LongTermDebtMaturitiesCouponInterestPaymentsAndFinancingFees
11500000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4119000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3141000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
25002000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
14269000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
46531000
CY2019Q4 qure Common Stock Shares Authorized Value
CommonStockSharesAuthorizedValue
3000000.0
CY2019Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.12
CY2019Q4 qure Common Stock Shares Authorized Value
CommonStockSharesAuthorizedValue
3400000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2019Q4 qure Foreign Currency Translation Adjustment Reserve
ForeignCurrencyTranslationAdjustmentReserve
6700000
CY2018Q4 qure Foreign Currency Translation Adjustment Reserve
ForeignCurrencyTranslationAdjustmentReserve
7300000
CY2017Q4 qure Foreign Currency Translation Adjustment Reserve
ForeignCurrencyTranslationAdjustmentReserve
3800000
CY2019Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4891305
CY2019Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
46.00
CY2019Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
733695
CY2019Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
46.00
CY2019Q3 qure Gross Proceeds From Issuance Initial Public Offering
GrossProceedsFromIssuanceInitialPublicOffering
258800000
CY2019Q3 qure Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
242700000
CY2019Q3 qure Capitalized Stock Issuance Costs
CapitalizedStockIssuanceCosts
600000
CY2018Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5175000
CY2018Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
28.50
CY2018Q2 qure Gross Proceeds From Issuance Initial Public Offering
GrossProceedsFromIssuanceInitialPublicOffering
147500000
CY2018 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
138400000
CY2018Q2 qure Capitalized Stock Issuance Costs
CapitalizedStockIssuanceCosts
200000
CY2017Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5000000
CY2017Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
18.25
CY2017Q4 qure Gross Proceeds From Issuance Initial Public Offering
GrossProceedsFromIssuanceInitialPublicOffering
91300000
CY2017Q4 qure Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
85300000
CY2017Q4 qure Capitalized Stock Issuance Costs
CapitalizedStockIssuanceCosts
500000
CY2017Q4 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
114172
CY2017Q4 qure Class Of Warrant Or Right Converted
ClassOfWarrantOrRightConverted
128710
CY2017Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.10
CY2017Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
12.0
CY2018Q2 qure Shares Authorized Under Offering Program
SharesAuthorizedUnderOfferingProgram
5000000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17468000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10693000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10280000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17468000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10693000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10280000
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
32496000
CY2019 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y5M26D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0192
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0287
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0267
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0320
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0239
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0281
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
561000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1654000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1202000
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
817000
CY2019 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8813000
CY2019 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
128281000
CY2018 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
100114000
CY2017 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
96807000
CY2019 us-gaap Labor And Related Expense
LaborAndRelatedExpense
59130000
CY2018 us-gaap Labor And Related Expense
LaborAndRelatedExpense
46254000
CY2017 us-gaap Labor And Related Expense
LaborAndRelatedExpense
46373000
CY2019 qure Laboratory And Development Expense
LaboratoryAndDevelopmentExpense
30130000
CY2018 qure Laboratory And Development Expense
LaboratoryAndDevelopmentExpense
23596000
CY2017 qure Laboratory And Development Expense
LaboratoryAndDevelopmentExpense
17737000
CY2019 qure Office And Housing Expense
OfficeAndHousingExpense
10588000
CY2018 qure Office And Housing Expense
OfficeAndHousingExpense
7281000
CY2017 qure Office And Housing Expense
OfficeAndHousingExpense
9327000
CY2019 qure Legal And Advisory Professional Fees
LegalAndAdvisoryProfessionalFees
11297000
CY2018 qure Legal And Advisory Professional Fees
LegalAndAdvisoryProfessionalFees
7748000
CY2017 qure Legal And Advisory Professional Fees
LegalAndAdvisoryProfessionalFees
8121000
CY2019 qure Depreciation Amortization And Impairment Charges
DepreciationAmortizationAndImpairmentCharges
6669000
CY2018 qure Depreciation Amortization And Impairment Charges
DepreciationAmortizationAndImpairmentCharges
12415000
CY2017 qure Depreciation Amortization And Impairment Charges
DepreciationAmortizationAndImpairmentCharges
6779000
CY2018 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1618000
CY2017 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7653000
CY2019 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
32029000
CY2018 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
26646000
CY2017 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
25131000
CY2019 qure Share Based Compensation In Employee Benefits
ShareBasedCompensationInEmployeeBenefits
17533000
CY2018 qure Share Based Compensation In Employee Benefits
ShareBasedCompensationInEmployeeBenefits
10708000
CY2017 qure Share Based Compensation In Employee Benefits
ShareBasedCompensationInEmployeeBenefits
10280000
CY2019 qure Consultant Expenses
ConsultantExpenses
2464000
CY2018 qure Consultant Expenses
ConsultantExpenses
2974000
CY2017 qure Consultant Expenses
ConsultantExpenses
4758000
CY2019 qure Social Security Costs
SocialSecurityCosts
2727000
CY2018 qure Social Security Costs
SocialSecurityCosts
2231000
CY2017 qure Social Security Costs
SocialSecurityCosts
2077000
CY2019 qure Health Insurance
HealthInsurance
1933000
CY2018 qure Health Insurance
HealthInsurance
1750000
CY2017 qure Health Insurance
HealthInsurance
1536000
CY2019 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
650000
CY2018 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
628000
CY2017 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
802000
CY2019 us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
1794000
CY2018 us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
1317000
CY2017 us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
1789000
CY2019 us-gaap Labor And Related Expense
LaborAndRelatedExpense
59130000
CY2018 us-gaap Labor And Related Expense
LaborAndRelatedExpense
46254000
CY2017 us-gaap Labor And Related Expense
LaborAndRelatedExpense
46373000
CY2019Q4 dei Entity Number Of Employees
EntityNumberOfEmployees
248
CY2018Q4 dei Entity Number Of Employees
EntityNumberOfEmployees
212
CY2017Q4 dei Entity Number Of Employees
EntityNumberOfEmployees
202
CY2018 qure Gain On Sale Of Derivatives
GainOnSaleOfDerivatives
208000
CY2018 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
208000
CY2019 qure Loss On Sale Of Derivatives
LossOnSaleOfDerivatives
2530000
CY2017 qure Loss On Sale Of Derivatives
LossOnSaleOfDerivatives
2192000
CY2017 qure Finance Expenses On Derivatives
FinanceExpensesOnDerivatives
243000
CY2019 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2530000
CY2017 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2435000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2530000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
208000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2435000
CY2019 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-111820000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-85721000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-60966000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-124201000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-83073000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-79459000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
22000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
10000
CY2018 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
209000
CY2017 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-209000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
209000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-209000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
231000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-199000
CY2019Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
6676000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
6484000
CY2018Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
7481000
CY2019Q4 qure Deferred Tax Liability Right Of Use Asset
DeferredTaxLiabilityRightOfUseAsset
6484000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6484000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-124201000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-83073000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-79459000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-31050000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-20768000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-19865000
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
495000
CY2018 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
106000
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-1664000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
25583000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
19207000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
17358000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
4972000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
2648000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
3248000
CY2018 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-962000
CY2017 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
724000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
231000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-199000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
4400000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
2700000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
2500000
CY2019 qure Income Tax Reconciliation Nondeductible Expense Derivative Financial Instruments
IncomeTaxReconciliationNondeductibleExpenseDerivativeFinancialInstruments
600000
CY2018 qure Income Tax Reconciliation Nondeductible Expense Derivative Financial Instruments
IncomeTaxReconciliationNondeductibleExpenseDerivativeFinancialInstruments
0.0
CY2017 qure Income Tax Reconciliation Nondeductible Expense Derivative Financial Instruments
IncomeTaxReconciliationNondeductibleExpenseDerivativeFinancialInstruments
500000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
99644000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
74529000
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
770000
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
847000
CY2019Q4 qure Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
7861000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
628000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
1682000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
116340000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
85100000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
109856000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
85100000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
85100000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
93682000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
82642000
CY2019 qure Valuation Allowance Deferred Tax Asset Changes Recorded In Profit And Loss
ValuationAllowanceDeferredTaxAssetChangesRecordedInProfitAndLoss
25583000
CY2018 qure Valuation Allowance Deferred Tax Asset Changes Recorded In Profit And Loss
ValuationAllowanceDeferredTaxAssetChangesRecordedInProfitAndLoss
19207000
CY2017 qure Valuation Allowance Deferred Tax Asset Changes Recorded In Profit And Loss
ValuationAllowanceDeferredTaxAssetChangesRecordedInProfitAndLoss
19080000
CY2019 qure Valuation Allowance Deferred Tax Asset Changes Recorded In Profit And Loss Related To Tax Reform
ValuationAllowanceDeferredTaxAssetChangesRecordedInProfitAndLossRelatedToTaxReform
4059000
CY2018 qure Valuation Allowance Deferred Tax Asset Changes Recorded In Profit And Loss Related To Tax Reform
ValuationAllowanceDeferredTaxAssetChangesRecordedInProfitAndLossRelatedToTaxReform
-15670000
CY2019 qure Valuation Allowance Deferred Tax Asset Currency Translation Effects
ValuationAllowanceDeferredTaxAssetCurrencyTranslationEffects
-4886000
CY2018 qure Valuation Allowance Deferred Tax Asset Currency Translation Effects
ValuationAllowanceDeferredTaxAssetCurrencyTranslationEffects
-5890000
CY2017 qure Valuation Allowance Deferred Tax Asset Currency Translation Effects
ValuationAllowanceDeferredTaxAssetCurrencyTranslationEffects
-6318000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
109856000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
85100000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
93682000
CY2019 qure Operating Loss Carryforwards Realized
OperatingLossCarryforwardsRealized
3700000
CY2018 qure Operating Loss Carryforwards Realized
OperatingLossCarryforwardsRealized
4500000
CY2017 qure Operating Loss Carryforwards Realized
OperatingLossCarryforwardsRealized
0.0
CY2019Q4 qure Valuation Allowance For Deferred Tax Assets Within Contributed Capital As It Relates To Follow On Offering Costs
ValuationAllowanceForDeferredTaxAssetsWithinContributedCapitalAsItRelatesToFollowOnOfferingCosts
6900000
CY2018Q4 qure Valuation Allowance For Deferred Tax Assets Within Contributed Capital As It Relates To Follow On Offering Costs
ValuationAllowanceForDeferredTaxAssetsWithinContributedCapitalAsItRelatesToFollowOnOfferingCosts
3300000
CY2019Q1 qure Operating Loss Carryforwards Term
OperatingLossCarryforwardsTerm
P6Y
CY2019 qure Operating Loss Carryforwards Term
OperatingLossCarryforwardsTerm
P9Y
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
414000000.0
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
311700000
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
246000000.0
CY2018 qure Operating Loss Carry Forwards Maximum Utilization Percentage Of Taxable Income
OperatingLossCarryForwardsMaximumUtilizationPercentageOfTaxableIncome
0.80
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12440841
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12108956
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10561163
CY2017Q3 qure Base Salary
BaseSalary
200000
CY2017Q3 qure Holiday Allowance Percentage Paid Annually
HolidayAllowancePercentagePaidAnnually
0.08
CY2017Q3 qure Maximum Bonus Percentage
MaximumBonusPercentage
0.40

Files In Submission

Name View Source Status
0001558370-20-001883-index-headers.html Edgar Link pending
0001558370-20-001883-index.html Edgar Link pending
0001558370-20-001883.txt Edgar Link pending
0001558370-20-001883-xbrl.zip Edgar Link pending
ex-10d49.htm Edgar Link pending
ex-10d49g001.jpg Edgar Link pending
ex-10d50.htm Edgar Link pending
ex-10d51.htm Edgar Link pending
ex-10d52.htm Edgar Link pending
ex-21d1.htm Edgar Link pending
ex-23d1.htm Edgar Link pending
ex-23d2.htm Edgar Link pending
ex-31d1.htm Edgar Link pending
ex-31d2.htm Edgar Link pending
ex-32d1.htm Edgar Link pending
ex-4d1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qure-20191231.xsd Edgar Link pending
qure-20191231x10k5849ab.htm Edgar Link pending
qure-20191231x10k5849ab001.jpg Edgar Link pending
qure-20191231x10k5849ab002.jpg Edgar Link pending
qure-20191231x10k5849ab_htm.xml Edgar Link completed
qure-20191231_cal.xml Edgar Link unprocessable
qure-20191231_def.xml Edgar Link unprocessable
qure-20191231_lab.xml Edgar Link unprocessable
qure-20191231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending